A major factor that has contributed to this failure to launch is that in tumors like BC, HER2 overexpression is primarily driven by gene amplification via an increased copy number of the ERBB2 gene, which is located on chromosome 17 [8,61]. The gene discussed is ERBB2; the disease is breast cancer.